The Latest Breaking News from CVS

Recent data indicates the signs of slowing down inflation. Additionally, the Fed is leaning toward slowing its pace of rate hikes. Amid this, fundamentally strong stocks Johnson & Johnson (JNJ), CVS Health (CVS), Douglas Dynamics (PLOW), and Genie Energy (GNE) might be ideal additions to your portfolio this winter. Continue…

Battle-tested business leaders from CVS, Southwest Airlines, Honeywell and other Fortune 500 companies share their best ideas for navigating a downturn.

Among the more remarkable legacies of the COVID-19 pandemic is how quickly federal regulators, the health care industry and consumers moved to make at-home testing a reliable tool for managing a public health crisis.

If you haven’t had your COVID-19 fall 2022 booster, now is the time, Chicago Public Health Commissioner Dr. Allison Arwady said.

Don't worry, last minute shoppers. You have options.

The healthcare industry is expected to witness significant growth in the foreseeable future, driven by rising health awareness, an aging population, and increasing chronic diseases worldwide. Furthermore, the healthcare industry is known to perform steadily regardless of economic conditions because of the inelastic demand for healthcare products and services. Therefore,…

The market has been under pressure amid high inflation, rising interest rates, and a slowing economy. Amid lingering macro headwinds, dividend investing could help investors ensure a steady income stream. Therefore, quality dividend stocks, CVS Health (CVS) and Spok Holdings (SPOK) could be ideal investments to navigate through tough times…

Tentative agreement would bring settlement total from lawsuits against various companies to more than $50bn.

NEW YORK — Walmart agreed to pay $3.1 billion to resolve lawsuits accusing the pharmacy of selling drugs that contributed to the opioid epidemic, but denied the allegations and didn’t admit liability.